Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that ...

Research from investigators at Rutgers Cancer Institute of New Jersey and the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, shows the intracellular process of ...

A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the University of Missouri, Cancer Targeted Technology (CTT) and ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

A UCLA neurobiology professor and prostate cancer survivor discuss using artificial intelligence to map his disease and inform treatment decisions. Artificial intelligence (AI) has the potential to ...

Researchers at Columbia University Irving Medical Center have identified a gene that drives the development of neuroendocrine ...

The breakthrough at Columbia University lays the groundwork for future clinical studies aimed at developing new treatments.

Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment. This is a synopsis of an Educated Patient ...

Prostate cancer screening is one of the most common decisions men face in primary care, yet many patients make that choice without fully understanding the potential benefits and harms. A new editorial ...

A groundbreaking new study suggests that prostate cancer treatment may soon become faster, simpler, and less disruptive for thousands of men across the United States.

The UK National Screening Committee has decided against vouching for population-wide testing, so who will get access and who ...